This step also screens for state eligibility, since Willow currently operates in only 34 states
[1] Liraglutide (Victoza, Saxenda): These formulations follow a 30-day rule after first use
While GLP-1 medications offer several benefits, they also come with limitations and downsides that patients and healthcare providers need to consider
Prebiotic supports digestive health and regularity extends GLP-1 lifespan for prolonged effects on glucose regulation and hunger suppression.*
Novo Nordisk (Wegovy / semaglutide) first mover, biggest revenue base, but facing supply constraints and pricing pressure
For patients currently using licensed injectable GLP-1 receptor agonists in the UK: Once-daily formulations include liraglutide (Victoza) [2] Once-weekly formulations include semaglutide (Ozempic), dulaglutide (Trulicity), and exenatide extended-release (Bydureon) [1] [2] If you are participating in a clinical trial involving a GLP-1 patch, you must strictly follow the specific instructions provided by the research team regarding application duration, replacement schedule, and all other aspects of use
